Jane Street
RLAY icon

Jane Street’s Relay Therapeutics RLAY Stock Holding History

Jane Street’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-423,536
Closed -$6.15M – 12878
2026
Q1 		$4.21M Buy
423,536
+347,060
+454% +$3.1M ﹤0.01% 3755
2025
Q4 		$647K Sell
76,476
-108,475
-59% -$774K ﹤0.01% 7131
2025
Q3 		$965K Buy
+184,951
New +$705K ﹤0.01% 6382
2025
Q2 		– Sell
-111,472
Closed -$292K – 10684
2025
Q1 		$292K Buy
111,472
+35,962
+48% +$141K ﹤0.01% 7853
2024
Q4 		$311K Sell
75,510
-109,819
-59% -$598K ﹤0.01% 7679
2024
Q3 		$1.31M Sell
185,329
-13,073
-7% -$97.7K ﹤0.01% 5329
2024
Q2 		$1.29M Buy
198,402
+56,963
+40% +$389K ﹤0.01% 5280
2024
Q1 		$1.17M Buy
141,439
+88,201
+166% +$860K ﹤0.01% 5109
2023
Q4 		$586K Sell
53,238
-187,432
-78% -$1.58M ﹤0.01% 6488
2023
Q3 		$2.02M Buy
240,670
+179,158
+291% +$1.93M ﹤0.01% 4037
2023
Q2 		$773K Buy
61,512
+15,920
+35% +$198K ﹤0.01% 5644
2023
Q1 		$751K Buy
45,592
+33,588
+280% +$602K ﹤0.01% 5579
2022
Q4 		$179K Buy
+12,004
New +$230K ﹤0.01% 7746
2022
Q3 		– Sell
-19,716
Closed -$433K – 10333
2022
Q2 		$330K Sell
19,716
-6,047
-23% -$130K ﹤0.01% 7459
2022
Q1 		$771K Buy
+25,763
New +$625K ﹤0.01% 6665
2021
Q4 		– Sell
-19,364
Closed -$611K – 10705
2021
Q3 		$611K Buy
+19,364
New +$652K ﹤0.01% 6899
2021
Q2 		– Sell
-17,778
Closed -$615K – 10308
2021
Q1 		$615K Buy
+17,778
New +$772K ﹤0.01% 6427

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Jane Street's RLAY Position: Q2 2026 in Review

Jane Street sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 423,536 shares — an estimated $6.15M sold.

Jane Street first reported a position in RLAY in Q1 2021 and held it in 17 quarters. The position peaked at $4.21M in Q1 2026. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jane Street reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 423,536 Relay Therapeutics shares in Q2 2026, an estimated $6.15M.
  • Jane Street first reported a position in Relay Therapeutics in Q1 2021 and held it in 17 quarters.
  • Jane Street's Relay Therapeutics position peaked at $4.21M in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.